NCT07033013View on ClinicalTrials.gov

A Randomized, Double Blind, Placebo Controlled, Clinical Study to Examine the Benefits of an Oral Product in Panelists With Menopausal Symptoms Including Vasomotor Symptoms (VMS).

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 7, 2025

Primary Completion Date

July 25, 2025

Study Completion Date

August 1, 2025

Conditions
Healthy
Interventions
DIETARY_SUPPLEMENT

Placebo

Placebo

DIETARY_SUPPLEMENT

Dietary Supplement with actives

Dietary supplement containing EstroG-100 and GABA

Trial Locations (1)

94132

RECRUITING

San Francisco Research Institute, San Francisco

All Listed Sponsors
lead

Olly, PBC

INDUSTRY

NCT07033013 - A Randomized, Double Blind, Placebo Controlled, Clinical Study to Examine the Benefits of an Oral Product in Panelists With Menopausal Symptoms Including Vasomotor Symptoms (VMS). | Biotech Hunter | Biotech Hunter